DEGHOR 120MG INJ

Brand: DEGHOR 120MG INJ
Composition: Degarelix.
Company: Glenmark
Form : injection
Packing: 1 vail in 1 box
Storage: Store in a refrigerator (2 – 8°C).
Share :

Related Products

DEGHOR 120MG INJ is a prescription medication used to treat certain types of prostate cancer. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the production of hormones that stimulate the growth of prostate cancer cells. Composition: Each vial of DEGHOR 120MG INJ contains 120mg of degarelix. Mechanism of Action: Degarelix works by:
  • Binding to the GnRH receptor, thereby blocking the binding of endogenous GnRH
  • Inhibiting the release of gonadotropins, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Reducing the production of androgens, such as testosterone, which are essential for the growth and progression of prostate cancer cells
Uses: DEGHOR 120MG INJ is used to treat:
  • Advanced hormone-sensitive prostate cancer in patients who have not responded to or have relapsed after treatment with luteinizing hormone-releasing hormone (LH-RH) agonists or anti-androgens
  • Hormone-sensitive prostate cancer in patients who have not received previous treatment with LH-RH agonists or anti-androgens
Dosage: The recommended dosage of DEGHOR 120MG INJ is:
  • 240mg (two 120mg vials) administered as an intramuscular injection on day 1 and then every 28 days thereafter
Side Effects: Common side effects of DEGHOR 120MG INJ include:
  • Injection site reactions
  • Increased risk of infections
  • Fatigue
  • Diarrhea
  • Nausea and vomiting
  • Increased risk of cardiovascular events
  • Increased risk of bone fractures
Recommendation: DEGHOR 120MG INJ is recommended for patients who have not responded to or have relapsed after treatment with LH-RH agonists or anti-androgens. Patients should also be advised to monitor their blood counts and liver function regularly during treatment. Important Note: Patients should not take DEGHOR 120MG INJ if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking DEGHOR 120MG INJ. Some common brands of degarelix include:
  • FIRMAGON (Ferring Pharmaceuticals)
  • Firmagon (Ferring Pharmaceuticals)
Please note that DEGHOR 120MG INJ is not available in all markets and may be approved for different indications and dosages in different regions.

DEGHOR 120MG INJ is a prescription medication used to treat certain types of prostate cancer. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the production of hormones that stimulate the growth of prostate cancer cells.

Composition:

Each vial of DEGHOR 120MG INJ contains 120mg of degarelix.

Mechanism of Action:

Degarelix works by:

  • Binding to the GnRH receptor, thereby blocking the binding of endogenous GnRH
  • Inhibiting the release of gonadotropins, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Reducing the production of androgens, such as testosterone, which are essential for the growth and progression of prostate cancer cells

Uses:

DEGHOR 120MG INJ is used to treat:

  • Advanced hormone-sensitive prostate cancer in patients who have not responded to or have relapsed after treatment with luteinizing hormone-releasing hormone (LH-RH) agonists or anti-androgens
  • Hormone-sensitive prostate cancer in patients who have not received previous treatment with LH-RH agonists or anti-androgens

Dosage:

The recommended dosage of DEGHOR 120MG INJ is:

  • 240mg (two 120mg vials) administered as an intramuscular injection on day 1 and then every 28 days thereafter

Side Effects:

Common side effects of DEGHOR 120MG INJ include:

  • Injection site reactions
  • Increased risk of infections
  • Fatigue
  • Diarrhea
  • Nausea and vomiting
  • Increased risk of cardiovascular events
  • Increased risk of bone fractures

Recommendation:

DEGHOR 120MG INJ is recommended for patients who have not responded to or have relapsed after treatment with LH-RH agonists or anti-androgens. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take DEGHOR 120MG INJ if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking DEGHOR 120MG INJ.

Some common brands of degarelix include:

  • FIRMAGON (Ferring Pharmaceuticals)
  • Firmagon (Ferring Pharmaceuticals)

Please note that DEGHOR 120MG INJ is not available in all markets and may be approved for different indications and dosages in different regions.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

DEGHOR 120MG INJ is a prescription medication used to treat certain types of prostate cancer. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the production of hormones that stimulate the growth of prostate cancer cells.

Composition:

Each vial of DEGHOR 120MG INJ contains 120mg of degarelix.

Mechanism of Action:

Degarelix works by:

  • Binding to the GnRH receptor, thereby blocking the binding of endogenous GnRH
  • Inhibiting the release of gonadotropins, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Reducing the production of androgens, such as testosterone, which are essential for the growth and progression of prostate cancer cells

Uses:

DEGHOR 120MG INJ is used to treat:

  • Advanced hormone-sensitive prostate cancer in patients who have not responded to or have relapsed after treatment with luteinizing hormone-releasing hormone (LH-RH) agonists or anti-androgens
  • Hormone-sensitive prostate cancer in patients who have not received previous treatment with LH-RH agonists or anti-androgens

Dosage:

The recommended dosage of DEGHOR 120MG INJ is:

  • 240mg (two 120mg vials) administered as an intramuscular injection on day 1 and then every 28 days thereafter

Side Effects:

Common side effects of DEGHOR 120MG INJ include:

  • Injection site reactions
  • Increased risk of infections
  • Fatigue
  • Diarrhea
  • Nausea and vomiting
  • Increased risk of cardiovascular events
  • Increased risk of bone fractures

Recommendation:

DEGHOR 120MG INJ is recommended for patients who have not responded to or have relapsed after treatment with LH-RH agonists or anti-androgens. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take DEGHOR 120MG INJ if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking DEGHOR 120MG INJ.

Some common brands of degarelix include:

  • FIRMAGON (Ferring Pharmaceuticals)
  • Firmagon (Ferring Pharmaceuticals)

Please note that DEGHOR 120MG INJ is not available in all markets and may be approved for different indications and dosages in different regions.

Reviews

There are no reviews yet.

Be the first to review “DEGHOR 120MG INJ”

Your email address will not be published. Required fields are marked *

DEGHOR 120MG INJ is a prescription medication used to treat certain types of prostate cancer. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which works by blocking the production of hormones that stimulate the growth of prostate cancer cells.

Composition:

Each vial of DEGHOR 120MG INJ contains 120mg of degarelix.

Mechanism of Action:

Degarelix works by:

  • Binding to the GnRH receptor, thereby blocking the binding of endogenous GnRH
  • Inhibiting the release of gonadotropins, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
  • Reducing the production of androgens, such as testosterone, which are essential for the growth and progression of prostate cancer cells

Uses:

DEGHOR 120MG INJ is used to treat:

  • Advanced hormone-sensitive prostate cancer in patients who have not responded to or have relapsed after treatment with luteinizing hormone-releasing hormone (LH-RH) agonists or anti-androgens
  • Hormone-sensitive prostate cancer in patients who have not received previous treatment with LH-RH agonists or anti-androgens

Dosage:

The recommended dosage of DEGHOR 120MG INJ is:

  • 240mg (two 120mg vials) administered as an intramuscular injection on day 1 and then every 28 days thereafter

Side Effects:

Common side effects of DEGHOR 120MG INJ include:

  • Injection site reactions
  • Increased risk of infections
  • Fatigue
  • Diarrhea
  • Nausea and vomiting
  • Increased risk of cardiovascular events
  • Increased risk of bone fractures

Recommendation:

DEGHOR 120MG INJ is recommended for patients who have not responded to or have relapsed after treatment with LH-RH agonists or anti-androgens. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take DEGHOR 120MG INJ if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking DEGHOR 120MG INJ.

Some common brands of degarelix include:

  • FIRMAGON (Ferring Pharmaceuticals)
  • Firmagon (Ferring Pharmaceuticals)

Please note that DEGHOR 120MG INJ is not available in all markets and may be approved for different indications and dosages in different regions.

Reviews

There are no reviews yet.

Be the first to review “DEGHOR 120MG INJ”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For DEGHOR 120MG INJ